 Neoplasm Staging
"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
- Staging, Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 2 | 2 | | 1982 | 0 | 2 | 2 | | 1984 | 0 | 1 | 1 | | 1985 | 0 | 3 | 3 | | 1986 | 0 | 2 | 2 | | 1987 | 0 | 2 | 2 | | 1988 | 0 | 4 | 4 | | 1989 | 0 | 3 | 3 | | 1990 | 0 | 6 | 6 | | 1991 | 0 | 7 | 7 | | 1992 | 0 | 5 | 5 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 6 | 6 | | 1995 | 0 | 8 | 8 | | 1996 | 0 | 1 | 1 | | 1997 | 0 | 7 | 7 | | 1998 | 0 | 4 | 4 | | 1999 | 0 | 5 | 5 | | 2000 | 0 | 6 | 6 | | 2001 | 0 | 5 | 5 | | 2002 | 1 | 12 | 13 | | 2003 | 0 | 10 | 10 | | 2004 | 0 | 8 | 8 | | 2005 | 1 | 12 | 13 | | 2006 | 0 | 12 | 12 | | 2007 | 2 | 8 | 10 | | 2008 | 3 | 12 | 15 | | 2009 | 0 | 24 | 24 | | 2010 | 0 | 24 | 24 | | 2011 | 0 | 14 | 14 | | 2012 | 0 | 20 | 20 | | 2013 | 0 | 16 | 16 | | 2014 | 0 | 16 | 16 | | 2015 | 1 | 20 | 21 | | 2016 | 0 | 16 | 16 | | 2017 | 1 | 13 | 14 | | 2018 | 2 | 17 | 19 | | 2019 | 4 | 11 | 15 | | 2020 | 0 | 6 | 6 | | 2021 | 1 | 9 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Foster CC, Fleming GF, Karrison TG, Liao CY, Desai AV, Moroney JW, Ratain MJ, Nanda R, Polite BN, Hahn OM, O'Donnell PH, Vokes EE, Kindler HL, Hseu R, Janisch LA, Dai J, Hoffman MD, Weichselbaum RR, Pitroda SP, Chmura SJ, Luke JJ. Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 10 15; 27(20):5510-5518.
-
Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, Falagario UG, Liu Y, Davicioni E, Spratt DE, Schaeffer EM, Feng FY, Mahal B, Nguyen PL, Den RB, Greenberger MD, Bradley R, Watson JM, Beamer M, Stamatakis L, Carmen DJ, Awasthi S, Hwang J, Weil R, Merisaari H, Mohamed N, Deane LA, Chakravarty D, Yadav KK, Yamoah K, Nair SS, Tewari AK. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol. 2021 06 03; 4(1):670.
-
Arndt AT, Brunelli A, Cicconi S, Falcoz PE, Salati M, Kozower B, Liptay MJ, Rocco G, Karush JM, Geissen N, Basu S, Seder CW. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
-
Lehrich BM, Abiri A, Goshtasbi K, Birkenbeuel J, Yasaka TM, Papagiannopoulos P, Tajudeen BA, Brem EA, Kuan EC. Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma. Laryngoscope. 2021 11; 131(11):E2727-E2735.
-
Gounder M, Abdul Razak AR, Gilligan AM, Leong H, Ma X, Somaiah N, Chawla SP, Martin-Broto J, Grignani G, Schuetze SM, Vincenzi B, Wagner AJ, Chmielowski B, Jones RL, Shah J, Shacham S, Kauffman M, Riedel RF, Attia S. Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma. Future Oncol. 2021 Aug; 17(22):2923-2939.
-
Talati VM, Urban MJ, Patel TR, Wojcik C, Tajudeen BA, Stenson K, Bhayani MK, Al-Khudari S, Husain IA. Laryngeal Chondrosarcoma Characteristics and Survival Analysis in the National Cancer Database. Otolaryngol Head Neck Surg. 2022 01; 166(1):101-108.
-
Walker CJ, Espinosa ML, Mehta-Shah N, Pro B, Guitart J, Kuzel T. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides. J Drugs Dermatol. 2021 03 01; 20(3):349-350.
-
Jones RL, Wagner AJ, Kawai A, Tamura K, Shahir A, Van Tine BA, MartÃn-Broto J, Peterson PM, Wright J, Tap WD. Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial. Clin Cancer Res. 2021 07 15; 27(14):3861-3866.
-
Leslie KK, Filiaci VL, Mallen AR, Thiel KW, Devor EJ, Moxley K, Richardson D, Mutch D, Secord AA, Tewari KS, McDonald ME, Mathews C, Cosgrove C, Dewdney S, Casablanca Y, Jackson A, Rose PG, Zhou X, McHale M, Lankes H, Levine DA, Aghajanian C. Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. Gynecol Oncol. 2021 04; 161(1):113-121.
-
Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 03; 490:112956.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|